{"slideshow_credits": null, "snippet": "The latest warning from the American regulator comes four months after it announced a ban on any imports made by another Ranbaxy factory.", "abstract": "The latest warning from the American regulator comes four months after it announced a ban on any imports made by another Ranbaxy factory.", "section_name": "World", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"lastname": "BAGRI", "rank": 1, "firstname": "Neha", "role": "reported", "organization": "", "middlename": "Thirani"}], "original": "By NEHA THIRANI BAGRI"}, "web_url": "http://india.blogs.nytimes.com/2014/01/13/ranbaxy-says-f-d-a-lists-possible-violations-at-punjab-drug-plant/", "lead_paragraph": null, "headline": {"main": "Ranbaxy Says F.D.A. Lists Possible Violations at Punjab Drug Plant", "kicker": "India Ink"}, "_id": "52d3ded338f0d825af31581b", "word_count": "625", "multimedia": [], "pub_date": "2014-01-13T07:38:27Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "glocations", "value": "India", "rank": "1"}, {"name": "glocations", "value": "New Delhi (India)", "rank": "3"}, {"name": "glocations", "value": "Mumbai (India)", "rank": "2"}, {"name": "organizations", "value": "Bombay Stock Exchange", "rank": "1"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": "2"}, {"name": "organizations", "value": "Ranbaxy Laboratories", "rank": "3"}, {"name": "subject", "value": "Fines (Penalties)", "rank": "3"}, {"name": "subject", "value": "Factories and Manufacturing", "rank": "2"}, {"name": "subject", "value": "Recalls and Bans of Products", "rank": "5"}, {"name": "subject", "value": "International Trade and World Market", "rank": "4"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Asia Pacific", "type_of_material": "Blog"}